[HTML][HTML] Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial

…, A Tibi, E Azoulay, J Cadranel… - JAMA internal …, 2021 - jamanetwork.com
Importance Severe pneumonia with hyperinflammation and elevated interleukin-6 is a common
presentation of coronavirus disease 2019 (COVID-19). Objective To determine whether …

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of …

VA Miller, V Hirsh, J Cadranel, YM Chen, K Park… - The lancet …, 2012 - thelancet.com
Background Afatinib, an irreversible ErbB-family blocker, has shown preclinical activity
when tested in EGFR mutant models with mutations that confer resistance to EGFR tyrosine-…

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

DW Denning, J Cadranel… - European …, 2016 - Eur Respiratory Soc
Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary
disease, complicating many other respiratory disorders, thought to affect ∼240 000 people in …

[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

…, RJM Brüggemann, D Buchheidt, J Cadranel… - Clinical Microbiology …, 2018 - Elsevier
The European Society for Clinical Microbiology and Infectious Diseases, the European
Confederation of Medical Mycology and the European Respiratory Society Joint Clinical …

[HTML][HTML] COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

…, AC Bettini, E Bria, M Brighenti, J Cadranel… - The Lancet …, 2020 - thelancet.com
Background Early reports on patients with cancer and COVID-19 have suggested a high
mortality rate compared with the general population. Patients with thoracic malignancies are …

[PDF][PDF] Long-term survival for patients with non–small-cell lung cancer with intratumoral lymphoid structures

…, S Lebecque, WH Fridman, J Cadranel - Journal of Clinical …, 2008 - researchgate.net
Purpose It has been established that the immune system plays an important role in tumor
rejection. There is also compelling evidence that immune responses can develop …

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

…, Q Tran, P Missy, A Langlais, B Milleron, J Cadranel… - The Lancet, 2016 - thelancet.com
Background The molecular profiling of patients with advanced non-small-cell lung cancer (NSCLC)
for known oncogenic drivers is recommended during routine care. Nationally, …

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

…, KM Antoniou, KK Brown, J Cadranel… - European …, 2015 - Eur Respiratory Soc
Many patients with an idiopathic interstitial pneumonia (IIP) have clinical features that suggest
an underlying autoimmune process but do not meet established criteria for a connective …

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

M Guiguet, F Boué, J Cadranel, JM Lang… - The lancet …, 2009 - thelancet.com
Background The relative roles of immunodeficiency, HIV viral load, and combination
antiretroviral therapy (cART) in the onset of individual cancers have rarely been examined. We …

Primary pulmonary lymphoma

J Cadranel, M Wislez, M Antoine - European Respiratory …, 2002 - Eur Respiratory Soc
Three distinct entities are now covered by the definition of primary pulmonary clonal lymphoid
proliferation. The aim of this review is to describe the pathophysiological, diagnostic, …